A SCIENTIST AT UNL WAS AWARDED MILLIONS FOR HIS WORK TO DEVELOP A CURE FOR HUMAN, HUMAN IMMUNODEFICIENCY VIRUS, OR HIV. HE’S HOPING THIS WILL END THE DECADES LONG SEARCH FOR ANSWERS. AND KETV ...

In the continuing search for the Achilles heel of HIV, researchers may finally be enjoying some success. This week, government researchers at the Vaccine Research Center of the National Institute of ...

It was compared to the Manhattan Project, but rather than build an atomic bomb, the U.S. government concentrated money and scientific talent to pursue a vaccine that had eluded researchers for more ...

A major challenge in developing a vaccine for HIV is that the virus mutates fast -- very fast. Although a person initially becomes infected with one or a few HIV strains, the virus replicates and ...

Many vaccines work because viruses stay relatively stable. HIV behaves differently; it mutates rapidly, creates many variants ...

Share on Pinterest The Trump administration’s plan to cut funding for HIV vaccine research comes at a time when the field is making progress. Victor Torres/Stocksy United The Trump administration ...

HIV has long stumped immunologists looking to develop an effective vaccine. All of the most promising approaches pioneered in the past three and a half decades have ultimately failed, and only a few ...

For nearly 15 years, Dennis Burton worked on a project aimed at solving what he calls "one of the most difficult problems in biomedicine" — creating an HIV vaccine. That work was funded by the largest ...

Termination of HIV vaccine studies affects key research institutions, aligning with previous cuts to HIV-related programs under the Trump administration. The administration plans to focus on existing ...

Please provide your email address to receive an email when new articles are posted on . Although there is still no HIV vaccine and no promising candidates in the pipeline, data published throughout ...

It is an emotional cycle familiar to most AIDS-vaccine researchers: the high of finally making measurable headway against HIV, followed by the crushing low of discovering that the virus has once again ...